Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inari Medical, Inc. (NARI) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inari Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1531048.
Total stock buying since 2020: $22,862,156.
Total stock sales since 2020: $572,644,121.
Total stock option exercises since 2020: $1,408,984.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 200,000 | $12,140,000 | 342,542 | $987,535 |
| 2024 | 0 | $0 | 602,224 | $30,067,094 | 36,000 | $16,452 |
| 2023 | 56,100 | $2,996,818 | 691,501 | $43,950,291 | 2,038,782 | $96,804 |
| 2022 | 0 | $0 | 671,192 | $53,381,804 | 334,966 | $144,833 |
| 2021 | 303 | $26,992 | 2,709,628 | $281,498,674 | 251,946 | $131,371 |
| 2020 | 1,044,077 | $19,838,346 | 2,121,800 | $151,606,258 | 70,000 | $31,989 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 0 | $0 | 0 | $0 | 342,542 | $987,535 |
| 2025-01 | 0 | $0 | 200,000 | $12,140,000 | 0 | $0 |
| 2024-12 | 0 | $0 | 67,000 | $3,730,675 | 0 | $0 |
| 2024-11 | 0 | $0 | 63,000 | $3,216,330 | 0 | $0 |
| 2024-10 | 0 | $0 | 83,000 | $3,959,000 | 0 | $0 |
| 2024-09 | 0 | $0 | 3,000 | $136,521 | 3,000 | $1,371 |
| 2024-08 | 0 | $0 | 68,000 | $3,355,050 | 5,000 | $2,285 |
| 2024-07 | 0 | $0 | 111,000 | $6,085,067 | 5,000 | $2,285 |
| 2024-06 | 0 | $0 | 45,260 | $2,033,532 | 5,000 | $2,285 |
| 2024-05 | 0 | $0 | 148,513 | $6,993,650 | 6,000 | $2,742 |
| 2024-04 | 0 | $0 | 7,451 | $303,800 | 6,000 | $2,742 |
| 2024-03 | 0 | $0 | 6,000 | $253,469 | 6,000 | $2,742 |
| 2023-12 | 0 | $0 | 31,500 | $2,037,424 | 109,992 | $47,264 |
| 2023-11 | 56,100 | $2,996,818 | 94,399 | $5,649,423 | 6,500 | $2,970 |
| 2023-10 | 0 | $0 | 31,500 | $1,774,072 | 6,500 | $2,970 |
| 2023-09 | 0 | $0 | 31,500 | $2,110,304 | 6,500 | $2,970 |
| 2023-08 | 0 | $0 | 68,102 | $4,566,710 | 6,500 | $2,970 |
| 2023-07 | 0 | $0 | 31,500 | $1,797,992 | 6,500 | $2,970 |
| 2023-06 | 0 | $0 | 81,500 | $4,737,787 | 6,500 | $2,970 |
| 2023-05 | 0 | $0 | 181,250 | $12,705,965 | 15,446 | $2,970 |
| 2023-04 | 0 | $0 | 37,750 | $2,443,702 | 6,500 | $2,970 |
| 2023-03 | 0 | $0 | 51,750 | $3,202,477 | 1,841,344 | $13,670 |
| 2023-02 | 0 | $0 | 31,750 | $1,752,572 | 16,500 | $7,540 |
| 2023-01 | 0 | $0 | 19,000 | $1,171,863 | 10,000 | $4,570 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-10 | Hykes Andrew (President and CEO) | Option Ex | 194,538 | 2.45 | 476,034 |
| 2025-02-10 | Tu Thomas (Chief Medical Officer) | Option Ex | 148,004 | 3.46 | 511,501 |
| 2025-01-06 | Hoffman William (Director) | Sale | 200,000 | 60.70 | 12,140,000 |
| 2024-12-20 | Hykes Andrew (President and CEO) | Sale | 3,000 | 55.42 | 166,275 |
| 2024-12-16 | Hoffman William (Director) | Sale | 60,000 | 55.74 | 3,344,400 |
| 2024-12-10 | Tu Thomas (Chief Medical Officer) | Sale | 4,000 | 55.00 | 220,000 |
| 2024-11-20 | Hykes Andrew (President and CEO) | Sale | 3,000 | 50.83 | 152,490 |
| 2024-11-18 | Hoffman William (Director) | Sale | 60,000 | 51.06 | 3,063,840 |
| 2024-10-29 | Hykes Andrew (President and CEO) | Sale | 3,000 | 50.00 | 150,000 |
| 2024-10-29 | Hoffman William (Director) | Sale | 40,000 | 50.05 | 2,002,000 |
| 2024-10-16 | Hoffman William (Director) | Sale | 40,000 | 45.17 | 1,807,000 |
| 2024-09-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 3,000 | 45.51 | 136,521 |
| 2024-09-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 3,000 | .46 | 1,371 |
| 2024-08-20 | Hykes Andrew (President and CEO) | Sale | 3,000 | 50.00 | 150,000 |
| 2024-08-19 | Hoffman William (Director) | Sale | 20,000 | 50.30 | 1,006,000 |
| 2024-08-16 | Hoffman William (Director) | Sale | 40,000 | 48.95 | 1,957,800 |
| 2024-08-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 5,000 | 48.25 | 241,250 |
| 2024-08-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 5,000 | .46 | 2,285 |
| 2024-07-22 | Hykes Andrew (President and CEO) | Sale | 3,000 | 55.23 | 165,690 |
| 2024-07-16 | Tu Thomas (Chief Medical Officer) | Sale | 3,480 | 55.16 | 191,956 |
| 2024-07-16 | Hoffman William (Director) | Sale | 60,000 | 56.57 | 3,394,020 |
| 2024-07-15 | Tu Thomas (Chief Medical Officer) | Sale | 16,520 | 55.09 | 910,086 |
| 2024-07-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 5,000 | 54.02 | 270,075 |
| 2024-07-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 5,000 | .46 | 2,285 |
| 2024-07-01 | Hykes Andrew (President and CEO) | Sale | 3,000 | 50.08 | 150,240 |
| 2024-07-01 | Hoffman William (Director) | Sale | 20,000 | 50.15 | 1,003,000 |
| 2024-06-21 | Chambers Rebecca (Director) | Sale | 260 | 45.99 | 11,957 |
| 2024-06-17 | Hoffman William (Director) | Sale | 40,000 | 44.59 | 1,783,600 |
| 2024-06-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 5,000 | 47.59 | 237,975 |
| 2024-06-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 5,000 | .46 | 2,285 |
| 2024-05-28 | Hykes Andrew (President and CEO) | Sale | 3,000 | 50.00 | 150,000 |
| 2024-05-28 | Hoffman William (Director) | Sale | 60,000 | 50.13 | 3,007,800 |
| 2024-05-20 | Chambers Rebecca (Director) | Sale | 964 | 45.39 | 43,755 |
| 2024-05-16 | Hoffman William (Director) | Sale | 40,000 | 46.76 | 1,870,200 |
| 2024-05-13 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,000 | 45.59 | 273,540 |
| 2024-05-13 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,000 | .46 | 2,742 |
| 2024-05-01 | Hoffman William (Director) | Sale | 38,549 | 42.76 | 1,648,355 |
| 2024-04-16 | Hoffman William (Director) | Sale | 1,451 | 40.00 | 58,040 |
| 2024-04-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,000 | 40.96 | 245,760 |
| 2024-04-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,000 | .46 | 2,742 |
| 2024-03-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,000 | 42.24 | 253,469 |
| 2024-03-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,000 | .46 | 2,742 |
| 2023-12-15 | Hoffman William (Director) | Sale | 25,000 | 65.19 | 1,629,874 |
| 2023-12-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 62.70 | 407,550 |
| 2023-12-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-12-04 | Hoffman William (Director) | Option Ex | 103,492 | .43 | 44,294 |
| 2023-11-16 | Hykes Andrew (President and CEO) | Sale | 37,448 | 59.87 | 2,241,824 |
| 2023-11-16 | Tu Thomas (Chief Medical Officer) | Sale | 25,451 | 59.87 | 1,523,624 |
| 2023-11-15 | Hoffman William (Director) | Sale | 25,000 | 60.75 | 1,518,675 |
| 2023-11-13 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 56.20 | 365,300 |
| 2023-11-13 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-11-08 | Milder Donald B (Director) | Buy | 2,100 | 52.88 | 111,058 |
| 2023-11-07 | Milder Donald B (Director) | Buy | 54,000 | 53.44 | 2,885,760 |
| 2023-10-16 | Hoffman William (Director) | Sale | 25,000 | 56.31 | 1,407,875 |
| 2023-10-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 56.34 | 366,197 |
| 2023-10-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-09-15 | Hoffman William (Director) | Sale | 25,000 | 66.85 | 1,671,249 |
| 2023-09-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 67.55 | 439,055 |
| 2023-09-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-08-16 | Hykes Andrew (President and CEO) | Sale | 36,676 | 66.74 | 2,447,866 |
| 2023-08-16 | Tu Thomas (Chief Medical Officer) | Sale | 24,926 | 66.74 | 1,663,636 |
| 2023-08-14 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 70.03 | 455,208 |
| 2023-08-14 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-07-17 | Hoffman William (Director) | Sale | 25,000 | 57.20 | 1,430,125 |
| 2023-07-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 56.59 | 367,867 |
| 2023-07-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-06-15 | Hoffman William (Director) | Sale | 50,000 | 58.00 | 2,900,150 |
| 2023-06-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 6,500 | 59.62 | 387,562 |
| 2023-06-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-05-27 | Nielsen Kirk G. (Director) | Option Ex | 2,982 | .00 | 0 |
| 2023-05-27 | Milder Donald B (Director) | Option Ex | 2,982 | .00 | 0 |
| 2023-05-27 | Root Jonathan D (Director) | Option Ex | 2,982 | .00 | 0 |
| 2023-05-17 | Hykes Andrew (President and CEO) | Sale | 18,760 | 69.19 | 1,298,004 |
| 2023-05-17 | Tu Thomas (Chief Medical Officer) | Sale | 12,751 | 69.19 | 882,241 |
| 2023-05-17 | Hoffman William (Director) | Sale | 41,891 | 69.19 | 2,898,438 |
| 2023-05-16 | Hykes Andrew (President and CEO) | Sale | 17,916 | 70.87 | 1,269,706 |
| 2023-05-16 | Tu Thomas (Chief Medical Officer) | Sale | 12,176 | 70.87 | 862,913 |
| 2023-05-16 | Hoffman William (Director) | Sale | 40,006 | 70.87 | 2,835,225 |
| 2023-05-15 | Hoffman William (Director) | Sale | 25,000 | 70.52 | 1,763,075 |
| 2023-05-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 70.30 | 896,363 |
| 2023-05-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-04-17 | Hoffman William (Director) | Sale | 25,000 | 64.72 | 1,618,000 |
| 2023-04-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 64.76 | 825,702 |
| 2023-04-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-03-20 | Hykes Andrew (President and CEO) | Sale | 9,000 | 64.45 | 580,095 |
| 2023-03-15 | Hoffman William (Director) | Sale | 25,000 | 63.28 | 1,582,000 |
| 2023-03-15 | Hoffman William (Director) | Option Ex | 25,000 | .43 | 10,700 |
| 2023-03-14 | Hoffman William (Director) | Sale | 5,000 | 60.10 | 300,500 |
| 2023-03-13 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 58.03 | 739,882 |
| 2023-03-13 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-03-12 | Hykes Andrew (President and CEO) | Option Ex | 430,517 | .00 | 0 |
| 2023-03-12 | Tu Thomas (Chief Medical Officer) | Option Ex | 292,584 | .00 | 0 |
| 2023-03-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 125,393 | .00 | 0 |
| 2023-03-12 | Hoffman William (Director) | Option Ex | 961,350 | .00 | 0 |
| 2023-02-27 | Tu Thomas (Chief Medical Officer) | Sale | 10,000 | 56.80 | 568,000 |
| 2023-02-27 | Tu Thomas (Chief Medical Officer) | Option Ex | 10,000 | .46 | 4,570 |
| 2023-02-21 | Hykes Andrew (President and CEO) | Sale | 9,000 | 55.19 | 496,710 |
| 2023-02-13 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 53.95 | 687,862 |
| 2023-02-13 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2023-01-27 | Tu Thomas (Chief Medical Officer) | Sale | 10,000 | 61.38 | 613,800 |
| 2023-01-27 | Tu Thomas (Chief Medical Officer) | Option Ex | 10,000 | .46 | 4,570 |
| 2023-01-20 | Hykes Andrew (President and CEO) | Sale | 9,000 | 62.01 | 558,063 |
| 2022-12-27 | Tu Thomas (Chief Medical Officer) | Sale | 20,000 | 64.24 | 1,284,800 |
| 2022-12-27 | Tu Thomas (Chief Medical Officer) | Option Ex | 20,000 | .46 | 9,140 |
| 2022-12-12 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 69.30 | 883,511 |
| 2022-12-12 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2022-11-15 | Hoffman William (President and CEO) | Sale | 55,000 | 81.61 | 4,488,330 |
| 2022-11-15 | Milder Donald B (Director) | Sale | 7,000 | 80.13 | 560,910 |
| 2022-11-14 | Hill, Mitch C. (Chief Financial Officer) | Sale | 12,750 | 79.19 | 1,009,710 |
| 2022-11-14 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 6,500 | .46 | 2,970 |
| 2022-10-27 | Tu Thomas (Chief Medical Officer) | Sale | 10,000 | 76.21 | 762,080 |
| 2022-10-20 | Hykes Andrew (Chief Operating Officer) | Sale | 9,000 | 72.63 | 653,652 |
| 2022-10-18 | Milder Donald B (Director) | Sale | 7,000 | 80.07 | 560,490 |
| 2022-10-17 | Hoffman William (President and CEO) | Sale | 55,000 | 75.28 | 4,140,235 |
| 2022-09-15 | Milder Donald B (Director) | Sale | 7,000 | 80.25 | 561,750 |
| 2022-09-09 | Hoffman William (President and CEO) | Sale | 13,692 | 76.71 | 1,050,272 |
| 2022-09-06 | Hykes Andrew (Chief Operating Officer) | Sale | 5,000 | 70.00 | 350,000 |
| 2022-08-15 | Hill, Mitch C. (Chief Financial Officer) | Sale | 7,500 | 81.85 | 613,860 |
| 2022-08-15 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 7,500 | .46 | 3,427 |
| 2022-08-15 | Milder Donald B (Director) | Sale | 7,000 | 81.46 | 570,199 |
| 2022-08-02 | Milder Donald B (Director) | Sale | 21,000 | 80.74 | 1,695,540 |
| 2022-08-01 | Hykes Andrew (Chief Operating Officer) | Sale | 5,000 | 78.47 | 392,350 |
| 2022-07-18 | Hoffman William (President and CEO) | Sale | 5,275 | 75.29 | 397,154 |
| 2022-07-15 | Hill, Mitch C. (Chief Financial Officer) | Sale | 7,500 | 72.73 | 545,475 |
| 2022-07-15 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 7,500 | .46 | 3,427 |
| 2022-07-08 | Hoffman William (President and CEO) | Sale | 11,237 | 75.58 | 849,292 |
| 2022-07-07 | Hoffman William (President and CEO) | Sale | 13,488 | 75.08 | 1,012,679 |
| 2022-07-06 | Hoffman William (President and CEO) | Sale | 30,000 | 72.50 | 2,175,090 |
| 2022-07-06 | Hoffman William (President and CEO) | Option Ex | 30,000 | .43 | 12,840 |
| 2022-07-05 | Hykes Andrew (Chief Operating Officer) | Sale | 5,000 | 70.31 | 351,550 |
| 2022-06-15 | Hill, Mitch C. (Chief Financial Officer) | Sale | 7,500 | 60.49 | 453,675 |
| 2022-06-15 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 7,500 | .46 | 3,427 |
| 2022-06-07 | Hykes Andrew (Chief Operating Officer) | Sale | 5,000 | 70.08 | 350,390 |
| 2022-06-06 | Hoffman William (President and CEO) | Sale | 30,000 | 67.94 | 2,038,290 |
| 2022-06-06 | Hoffman William (President and CEO) | Option Ex | 30,000 | .43 | 12,840 |
| 2022-05-27 | Nielsen Kirk G. (Director) | Option Ex | 2,983 | .00 | 0 |
| 2022-05-27 | Milder Donald B (Director) | Option Ex | 2,983 | .00 | 0 |
| 2022-05-16 | Hill, Mitch C. (Chief Financial Officer) | Sale | 7,500 | 59.05 | 442,860 |
| 2022-05-16 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 7,500 | .46 | 3,427 |
| 2022-05-10 | Tu Thomas (Chief Medical Officer) | Option Ex | 30,000 | .46 | 13,710 |
| 2022-05-05 | Hoffman William (President and CEO) | Sale | 30,000 | 75.22 | 2,256,660 |
| 2022-05-05 | Hoffman William (President and CEO) | Option Ex | 30,000 | .43 | 12,840 |
| 2022-05-02 | Hykes Andrew (Chief Operating Officer) | Sale | 5,000 | 79.65 | 398,250 |
| 2022-04-18 | Hill, Mitch C. (Chief Financial Officer) | Sale | 7,500 | 87.80 | 658,522 |
| 2022-04-18 | Hill, Mitch C. (Chief Financial Officer) | Option Ex | 7,500 | .46 | 3,427 |
| 2022-04-18 | Milder Donald B | Sale | 7,000 | 87.83 | 614,831 |
| 2022-04-05 | Hoffman William (President and CEO) | Sale | 30,000 | 89.73 | 2,691,810 |
| 2022-04-05 | Hoffman William (President and CEO) | Option Ex | 30,000 | .43 | 12,840 |
| 2022-04-01 | Hykes Andrew (Chief Operating Officer) | Sale | 10,000 | 91.22 | 912,159 |
| 2022-03-28 | Tu Thomas (Chief Medical Officer) | Sale | 2,000 | 90.00 | 180,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NARI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inari Medical, Inc. (symbol NARI, CIK number 1531048) see the Securities and Exchange Commission (SEC) website.